Efficacy and Safety of Deferasirox (Exjade (R)) in beta-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study

Pennell, Dudley J.Porter, John B.Cappellini, M. DomenicaChan, Lee LeeEl-Beshlawy, AmalAydinok, YesimIbrahim, HishamshahLi, Chi-KongViprakasit, VipElalfy, Mohsen SalehKattamis, AntonisSmith, GillianHabr, DanyDomokos, GaborRoubert, BernardTaher, Ali2019-10-272019-10-2720090006-4971https://hdl.handle.net/11454/4267851st Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2009 -- New Orleans, LAeninfo:eu-repo/semantics/closedAccessEfficacy and Safety of Deferasirox (Exjade (R)) in beta-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-StudyConference Object1142215581558WOS:000272725804725Q1